Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 29/10/2024 15:54:18 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3,581.284 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 5,601.612 EPS = 11.25 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2024 |
| 29/04/2024 12:34:11 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 5654.281 EPS = 1.78 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/12/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 959.905 |
| 26/03/2024 14:45:21 | ANNUAL GENERAL MEETING WILL BE HELD ON 24/04/2024 BOOK CLOSURE FROM 18/04/2024 BOOK CLOSURE TO 24/04/2024 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,177.300 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 533.953 EPS = 1.68 |
| 24/10/2023 15:42:20 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 255.480 PROFIT/LOSS AFTER TAXATION RS. IN MILLION (391.621) EPS = (1.23) |
| 22/08/2023 15:57:23 | EPS = (1.01) FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 350.922 PROFIT/LOSS AFTER TAXATION RS. IN MILLION (321.831) |